J A Kemp Authors the Whitepaper ‘Patent Filing Considerations in View of Revised EU Clinical Trial Regulation Transparency Rules’ with DLRC
In collaboration with DLRC, a leading Regulatory Affairs Consultancy, we’ve developed a white paper outlining key patent filing considerations. Authored by Karen Ng, and James Biddlecombe (Business Transformation & CTR Lead at DLRC Regulatory Consultancy), this paper emphasises the importance of early and ongoing collaboration between legal and regulatory teams throughout the life cycle of clinical trials to optimise patent filing opportunities.